These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32445565)

  • 61. Activation of human complement by the pneumococcal toxin pneumolysin.
    Paton JC; Rowan-Kelly B; Ferrante A
    Infect Immun; 1984 Mar; 43(3):1085-7. PubMed ID: 6698602
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pneumococcal Pneumolysin Induces DNA Damage and Cell Cycle Arrest.
    Rai P; He F; Kwang J; Engelward BP; Chow VT
    Sci Rep; 2016 Mar; 6():22972. PubMed ID: 27026501
    [TBL] [Abstract][Full Text] [Related]  

  • 63. β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection.
    Li H; Zhao X; Wang J; Dong Y; Meng S; Li R; Niu X; Deng X
    Sci Rep; 2015 Dec; 5():17668. PubMed ID: 26631364
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rapid and reliable identification of Streptococcus pneumoniae isolates by pneumolysin-mediated agglutination.
    Cima-Cabal MD; Vázquez F; de los Toyos JR; Méndez FJ
    J Clin Microbiol; 1999 Jun; 37(6):1964-6. PubMed ID: 10325355
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protection against bacteremic pneumococcal infection by antibody to pneumolysin.
    Musher DM; Phan HM; Baughn RE
    J Infect Dis; 2001 Mar; 183(5):827-30. PubMed ID: 11181163
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pneumolysin: a double-edged sword during the host-pathogen interaction.
    Marriott HM; Mitchell TJ; Dockrell DH
    Curr Mol Med; 2008 Sep; 8(6):497-509. PubMed ID: 18781957
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model.
    Benton KA; Paton JC; Briles DE
    Microb Pathog; 1997 Oct; 23(4):201-9. PubMed ID: 9344781
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Contribution of the ATP-dependent protease ClpCP to the autolysis and virulence of Streptococcus pneumoniae.
    Ibrahim YM; Kerr AR; Silva NA; Mitchell TJ
    Infect Immun; 2005 Feb; 73(2):730-40. PubMed ID: 15664911
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of pneumolysin in pneumococcal pneumonia and meningitis.
    Hirst RA; Kadioglu A; O'callaghan C; Andrew PW
    Clin Exp Immunol; 2004 Nov; 138(2):195-201. PubMed ID: 15498026
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis.
    Braun JS; Sublett JE; Freyer D; Mitchell TJ; Cleveland JL; Tuomanen EI; Weber JR
    J Clin Invest; 2002 Jan; 109(1):19-27. PubMed ID: 11781347
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quercetin, a pneumolysin inhibitor, protects mice against Streptococcus pneumoniae infection.
    Lv Q; Zhang P; Quan P; Cui M; Liu T; Yin Y; Chi G
    Microb Pathog; 2020 Mar; 140():103934. PubMed ID: 31862394
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Streptococcus pneumoniae: the role of apoptosis in host defense and pathogenesis.
    Marriott HM; Dockrell DH
    Int J Biochem Cell Biol; 2006; 38(11):1848-54. PubMed ID: 16844403
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.
    Ramos-Sevillano E; Urzainqui A; Campuzano S; Moscoso M; González-Camacho F; Domenech M; Rodríguez de Córdoba S; Sánchez-Madrid F; Brown JS; García E; Yuste J
    Infect Immun; 2015 Feb; 83(2):591-603. PubMed ID: 25404032
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Frontline Science: Escherichia coli use LPS as decoy to impair neutrophil chemotaxis and defeat antimicrobial host defense.
    Kondo Y; Ledderose C; Slubowski CJ; Fakhari M; Sumi Y; Sueyoshi K; Bezler AK; Aytan D; Arbab M; Junger WG
    J Leukoc Biol; 2019 Dec; 106(6):1211-1219. PubMed ID: 31392789
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Otitis-Prone Children Produce Functional Antibodies to Pneumolysin and Pneumococcal Polysaccharides.
    Kirkham LS; Wiertsema SP; Corscadden KJ; Mateus T; Mullaney GL; Zhang G; Richmond PC; Thornton RB
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28031178
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of human monocyte respiratory burst, degranulation, phospholipid methylation and bactericidal activity by pneumolysin.
    Nandoskar M; Ferrante A; Bates EJ; Hurst N; Paton JC
    Immunology; 1986 Dec; 59(4):515-20. PubMed ID: 3804376
    [TBL] [Abstract][Full Text] [Related]  

  • 77. α-Enolase of Streptococcus pneumoniae induces formation of neutrophil extracellular traps.
    Mori Y; Yamaguchi M; Terao Y; Hamada S; Ooshima T; Kawabata S
    J Biol Chem; 2012 Mar; 287(13):10472-10481. PubMed ID: 22262863
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pneumolysin induces platelet destruction, not platelet activation, which can be prevented by immunoglobulin preparations in vitro.
    Jahn K; Handtke S; Palankar R; Weißmüller S; Nouailles G; Kohler TP; Wesche J; Rohde M; Heinz C; Aschenbrenner AF; Wolff M; Schüttrumpf J; Witzenrath M; Hammerschmidt S; Greinacher A
    Blood Adv; 2020 Dec; 4(24):6315-6326. PubMed ID: 33351126
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reversion of Pneumolysin-Induced Executioner Caspase Activation Redirects Cells to Survival.
    Nerlich A; von Wunsch Teruel I; Mieth M; Hönzke K; Rückert JC; Mitchell TJ; Suttorp N; Hippenstiel S; Hocke AC
    J Infect Dis; 2021 Jun; 223(11):1973-1983. PubMed ID: 33045080
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pneumolysin-responsive liposomal platform for selective treatment of Streptococcus pneumoniae.
    Watt E; Andriescu I; Ho EA
    Drug Deliv Transl Res; 2024 Sep; ():. PubMed ID: 39285123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.